This free webinar explores the Cell & Gene Therapy Discussion Group's mission to map global regulatory frameworks, identify critical areas of divergence, and propose a strategic roadmap for international harmonization.
American Society of Gene & Cell Therapy
Non-profit Organizations
Waukesha, Wisconsin 38,970 followers
ASGCT is the primary membership organization for professionals working in gene and cell therapy.
About us
The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
- Website
-
https://www.asgct.org/
External link for American Society of Gene & Cell Therapy
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- Waukesha, Wisconsin
- Type
- Nonprofit
- Founded
- 1996
Locations
-
Primary
Get directions
20700 Swenson Dr
Suite 200
Waukesha, Wisconsin 53186, US
Employees at American Society of Gene & Cell Therapy
Updates
-
Get ready to meet the minds behind the medicine. 🧠 Host Eirini Vamva is bringing you Scientists, Unedited – a brand-new podcast highlighting the incredible people driving scientific progress, their journeys, and their lives beyond the lab. Subscribe to the ASGCT Podcast Network to catch monthly episodes starting in June: asgct.org/podcast
-
Patient advocate Christine Green (Finding Hope for Frizzle (FRRS1L)) joins host Benjamin McLeod to discuss her parent-led organization's mission to develop an FRRS1L treatment and how the ASGCT Annual Meeting helps bridge the gap between advocacy and scientific development. 🎧 Listen now: https://lnkd.in/g3ayFTZ3
-
-
Can RNA therapeutics close the gap for the 10% of cystic fibrosis patients without an approved treatment? Dr. Paloma Giangrande (MTNA) and Norm Allaire (Cystic Fibrosis Foundation) discuss an innovative new ASO-based approach in our latest episode. 🎧 Listen now: https://lnkd.in/gKx6zGkS
-
ASGCT submitted written testimony to three FY27 appropriations subcommittees urging robust funding for NIH, ARPA-H, and CBER – and led a sign-on letter from 100+ organizations in support. Read more in the Advocate: https://lnkd.in/gR_8iBEK #ASGCTAdvocacy
-
Divergent regulatory expectations remain a major hurdle for cell and gene therapy developers and patient access worldwide. Join us for a free webinar on June 24 to hear from the ICH Cell & Gene Therapy Discussion Group as they dive into: 🌍 Mapping global regulatory frameworks 🌎 Identifying critical areas of divergence 🌏 The roadmap for international harmonization Register now to watch live or on demand: https://lnkd.in/gjsV6sy8
-
-
What does it take to launch a successful career at the forefront of genetic medicine? Recorded live at #ASGCT2026, host Benjamin McLeod catches up with Dr. Marco Carpenter of the Children's Hospital of Philadelphia. As one of this year's ASGCT Career Development Award recipients, Dr. Carpenter discusses his research journey, the evolving landscape of cell and gene therapy, and how the ASGCT community supports early-career researchers. 🎧 Tune in to hear his story and find out how membership fuels professional growth: https://lnkd.in/g2PvYGnG
-
-
#ASGCT2026 brought together thousands of clinicians, scientists, industry leaders, and patient advocates for an incredible week of groundbreaking science and connection. Thank you to our brilliant speakers, dedicated sponsors, and every attendee who brought such inspiring energy to this year's meeting. The momentum we built this week will continue to drive the field of cell and gene therapy forward. Mark your calendars – we can't wait to see you all in Philadelphia for #ASGCT2027, May 3–7, 2027!
-
-
-
-
-
+8
-